InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,168.35
(
0.63%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.11
(
-0.05%
)
Bitcoin
64,366.56
(
-0.18%
)
Post# of 73
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 84
Posts 32174
Boards Moderated 85
Alias Born 03/22/2005

gfp927z

Re: None

Thursday, 07/24/2014 7:39:30 PM

Thursday, July 24, 2014 7:39:30 PM

Post# of 73
Organovo and J+J/Janssen Research -


>>> 24-Jul-2014

Regulation FD Disclosure



Item 7.01 Regulation FD Disclosure

On July 24, 2014, Organovo Holdings, Inc. (the "Company") announced that it has entered into an agreement with Janssen Research and Development (JRD), a pharmaceutical company of Johnson & Johnson, to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the Company's work in 3D liver tissue for toxicity testing. Terms have not been disclosed.

<<<


http://biz.yahoo.com/e/140724/onvo8-k.html


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up